Operating Expenses - Sesen Bio Inc (F:PCBK) - Alpha Spread
S

Sesen Bio Inc
F:PCBK

Watchlist Manager
Sesen Bio Inc
F:PCBK
Watchlist
Price: 0.5124 EUR 28.1%
Market Cap: 103.9m EUR
Have any thoughts about
Sesen Bio Inc?
Write Note

Sesen Bio Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sesen Bio Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
S
Sesen Bio Inc
F:PCBK
Operating Expenses
-$26.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$20.6B
CAGR 3-Years
-3%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.3B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.7B
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.5B
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
-18%

See Also

What is Sesen Bio Inc's Operating Expenses?
Operating Expenses
-26.4m USD

Based on the financial report for Dec 31, 2022, Sesen Bio Inc's Operating Expenses amounts to -26.4m USD.

Back to Top